open access

Vol 75, No 2 (2007)
ORIGINAL PAPERS
Published online: 2007-06-03
Submitted: 2013-02-22
Get Citation

Cyclohaler’s acceptance by asthma and COPD patients

Bernard Panaszek, Andrzej Emeryk, Marita Nittner-Marszalska, Ewa Bogacka, Krystyna Gietkiewicz, Zbigniew Machaj, Iwona Czerwińska-Pawluk, Anna Bednarek
Pneumonol Alergol Pol 2007;75(2):115-120.

open access

Vol 75, No 2 (2007)
ORIGINAL PAPERS
Published online: 2007-06-03
Submitted: 2013-02-22

Abstract


Introduction: The patients’ acceptance of the treatment scheme and their readiness to stick to the prescribed dosing is considered to be the most important condition on which successful treatment of asthma and COPD depends. With regard to this assumption, a study was designed whose aim was to find out how patients assess a particular powder inhaler, cyclohaler and to what degree they approve of its physical and technical features.
Material and methods: The study consisted in completing an anonymous questionnaire. The study group was recruited from asthmatic and COPD patients treated in outpatient units in Wroclaw and Lublin, Poland. 230 persons passed the recruitment stage, 220 completed the study.
Results: 96.4 and 94.5% of the patients ranked small size and low weight of the inhaler, respectively, as its most positive features, ranking the features higher than the device’s colour (respectively p = 0.003 and p = 0.02). Other features, like dust protection and comfortable mouthpiece won almost equally high evaluation (respectively 97.3 and 98.2%). Most patients assessed these features as more important than discretion and easy handling and transportation (respectively p = 0.015 and p = 0.028). A high percentage of the study group praised the inhaler’s technological efficacy. 94-96% at the least gave positive opinions about such features as: clear instruction, certainty of a dose’s intake, the possibility of checking the amount of inhaled doses.
Conclusion: The inhaler that was the object of the study enjoyed a high degree of acceptance mostly due to its features facilitating easy and efficient inhalation.

Abstract


Introduction: The patients’ acceptance of the treatment scheme and their readiness to stick to the prescribed dosing is considered to be the most important condition on which successful treatment of asthma and COPD depends. With regard to this assumption, a study was designed whose aim was to find out how patients assess a particular powder inhaler, cyclohaler and to what degree they approve of its physical and technical features.
Material and methods: The study consisted in completing an anonymous questionnaire. The study group was recruited from asthmatic and COPD patients treated in outpatient units in Wroclaw and Lublin, Poland. 230 persons passed the recruitment stage, 220 completed the study.
Results: 96.4 and 94.5% of the patients ranked small size and low weight of the inhaler, respectively, as its most positive features, ranking the features higher than the device’s colour (respectively p = 0.003 and p = 0.02). Other features, like dust protection and comfortable mouthpiece won almost equally high evaluation (respectively 97.3 and 98.2%). Most patients assessed these features as more important than discretion and easy handling and transportation (respectively p = 0.015 and p = 0.028). A high percentage of the study group praised the inhaler’s technological efficacy. 94-96% at the least gave positive opinions about such features as: clear instruction, certainty of a dose’s intake, the possibility of checking the amount of inhaled doses.
Conclusion: The inhaler that was the object of the study enjoyed a high degree of acceptance mostly due to its features facilitating easy and efficient inhalation.
Get Citation

Keywords

cyclohaler; treatment of COPD; treatment of asthma; compliance; properties of inhaler; user acceptance of inhaler

About this article
Title

Cyclohaler’s acceptance by asthma and COPD patients

Journal

Advances in Respiratory Medicine

Issue

Vol 75, No 2 (2007)

Pages

115-120

Published online

2007-06-03

Bibliographic record

Pneumonol Alergol Pol 2007;75(2):115-120.

Keywords

cyclohaler
treatment of COPD
treatment of asthma
compliance
properties of inhaler
user acceptance of inhaler

Authors

Bernard Panaszek
Andrzej Emeryk
Marita Nittner-Marszalska
Ewa Bogacka
Krystyna Gietkiewicz
Zbigniew Machaj
Iwona Czerwińska-Pawluk
Anna Bednarek

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Pneumonologia i Alergologia Polska dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl